Wingderm Receives FDA Clearance for Lasermach Across Three Wavelengths
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
The expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.
The company presented clinical data on its PCL-based collagen stimulator, positioning it within a shift toward treatments targeting skin laxity.
The device connects to standard operating room suction and is designed to support faster, more controlled explantation without requiring additional capital equipment or specialized training.
Plastic surgeons are calling for a ban on dermal fillers being injected into breasts, warning the procedure carries "unacceptable" risks.